Thermo Fisher Scientific Release: New Digital PCR-Based Research Solution Characterizes Hard-To-Detect Cancer Mutations

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific announced today the release of the QuantStudio 3D Rare Mutation Analysis Solution, a panel of wet-lab validated assays combined with an enhanced software tool that enables researchers to detect and quantify 40 of the most common mutations in cancer genes at a prevalence as low as 0.1 percent.

Tumor heterogeneity presents a significant barrier for clinical researchers to fully understand cancer samples with low-frequency mutations and, in turn, impedes future development of targeted strategies to address them. The ability to accurately characterize these complex tumors can help researchers better understand the root cause and progression of the disease.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC